Different effects of IGF-I on insulin-stimulated glucose uptake in adipose tissue and skeletal muscle

American Journal of Physiology - Endocrinology and Metabolism

Volumn 278, Issue 4 41-4, 2000, Pages

  Frick, Fredrik ^a   Oscarsson, Jan ^a   Vikman Adolfsson, Kerstin ^a   Ottosson, Malin ^b   Yoshida, Noriko ^b   Edén, Staffan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

C peptide; Cortisol; Free fatty acids; Glycogen; Insulin like growth factor I; L thyroxine; Lipid; Soleus muscle; Triglyceride

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE; GLYCOGEN; HYDROCORTISONE; INSULIN; LEVOTHYROXINE; LIPID; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; FEMALE; GLUCOSE TRANSPORT; HYPOPHYSECTOMY; LIPOLYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE;

EID: 0034002608     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.278.4.e729     Document Type: Article

References (48)

1. Bilan PJ, Mitsumoto Y, Ramlal T, and Klip A. Acute and long-term effects of insulin-like growth factor 1 on glucose transporters in muscle cells. FEBS Lett 298: 285-290, 1992.
2. Binoux M. The IGF system in metabolism regulation. Diabete Metab 21: 330-337, 1995.
3. Carlsson L, Nilsson I, and Oscarsson J. Hormonal regulation of liver fatty acid-binding protein in vivo and in vitro: effects of growth hormone and insulin. Endocrinology 139: 2699-2709, 1998.
4. Clemmons DR, Thissen JP, Maes M, Ketelslegers JM, and Underwood LE. Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized rats induces specific IGF-binding proteins in serum. Endocrinology 125: 2967-2972, 1989.
5. Dimitriadis G, Parry-Billings M, Dunger D, Bevan S, Colquhoun A, Taylor A, Calder P, Krause U, Wegener G, and Newsholme EA. Effects of in-vivo administration of insulin-like growth factor-1 on the rate of glucose utilization in the soleus muscle of the rat. J Endocrinol 133: 37-43, 1992.
6. Dole VP and Meinerz H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 235: 2595-2599, 1960.
7. Dunger DB, Cheetman TD, and Crowne EC. Insulin-like growth factors (IGFs) and IGF-1 treatment in the adolescent with insulin-dependent diabetes mellitus. Metabolism 44: 119-123, 1995.
8. Froesch ER, Schmid C, Schwander J, and Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol 47: 443-467, 1985.
9. Gause I, Edén S, DiGirolamo M, and Smith U. Changes in growth hormone binding and metabolic effects of growth hormone in rat adipocytes following hypophysectomy. Acta Physiol Scand 124: 229-238, 1985.
10. Gause I, Edén S, Jansson JO, and Isaksson O. Effects of in vivo administration of antiserum to rat growth hormone on body growth and insulin responsiveness in adipose tissue. Endocrinology 112: 1559-1566, 1983.
11. Gause I, Isaksson O, Lindahl A, and Edén S. Effect of insulin treatment of hypophysectomized rats on adipose tissue responsiveness to insulin and growth hormone. Endocrinology 116: 945-951, 1985.
12. Gliemann J, Österlind K, Vinten J, and Gammeltoft S. A procedure for measurement of distribution spaces in isolated fat cells. Biochim Biophys Acta 286: 1-9, 1972.
13. Guler HP, Zapf J, and Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor 1 in healthy adults. N Engl J Med 317: 137-140, 1987.
14. Guler HP, Zapf J, Schweiwiller E, and Froesch ER. Recombinant human insulin-like growth factor 1 stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 85: 4889-4893, 1988.
15. Hirsch J and Gallian E. Methods for the determination of adipose cell size in man and animals. J Lipid Res 9: 110-119, 1968.
16. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, and Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154: 138-143, 1986.
17. Humbel RE. Insulin-like growth factor 1 and II. Eur J Biochem 190: 445-462, 1990.
18. Hussain MA, Schmitz O, Christiansen JS, Zapf J, and Froesch ER. Metabolic effects of insulin-like growth factor-1: a focus on insulin sensitivity. Metabolism 44: 108-112, 1995.
19. Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J, and Froesch ER. Comparison effects of growth hormone and insulin-like growth factor 1 on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest 94: 1126-1133, 1994.
20. Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf J, and Froesch ER. Insulin-like growth factor 1 stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 92: 2249-2256, 1993.
21. Isgaard J, Carlsson L, Isaksson OP, and Jansson J. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor 1 messenger RNA in skeletal tissues more effectively than continuous GH infusion. Endocrinology 123: 2605-2610, 1988.
22. Jansson JO, Albertsson-Wikland K, Edén S, Thorngren KG, and Isaksson O. Circumstantial evidence for a role of the secretory pattern of growth hormone in control of body growth. Acta Endocrinol 99: 24-30, 1982.
23. Jansson JO, Albertsson-Wikland K, Edén S, Thorngren KG, and Isaksson O. Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats. Acta Physiol Scand 114: 261-265, 1982.
24. King GL, Kahn CR, Rechller MM, and Nissley SP. Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication stimulating activity (an insulin-like growth factor) using antibodies to the insulin receptors. J Clin Invest 66: 130-140, 1980.
25. Laron Z, Avitzur Y, and Klinger B. Carbohydrate metabolism in primary growth hormone resistance (Larons syndrome) before and during insulin-like growth factor-1 treatment. Metabolism 44: 113-118, 1995.
26. Laurell S and Tibbling G. An enzymatic fluorometric micromethod for the determination of glycerol. Clin Chem Acta 13: 317-322, 1966.
27. Leahy JL and Vandekerkhove KM. Insulin-like growth factor-1 at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 126: 1593-1598, 1990.
28. Lundholm K and Scherstén T. Gluconeogenesis in human liver tissue; an in vitro method for the evaluation of gluconeogenesis in man. Scared J Clin Lab Invest 36: 339-345, 1976.
29. Moses AD. Recombinant insulin-like growth factor-1 as therapy of altered carbohydrate homeostasis. Curr Op Endocrinol Diabetes 4: 16-25, 1997.
30. Mälkönen M and Manninen V. Faliure of thyoid hormones to maintain normal lipoprotein patterns after removal of the pituitary gland. Atherosclerosis 38: 121-128, 1981.
31. Oscarsson J, Olofsson S, Bondjers G, and Edén S. Differential effects of continuous vs. intermittent administration of growth hormone to hypophysectomized female rats on serum lipoproteins and their apoproteins. Endocrinology 125: 1638-1649, 1989.
32. Oscarsson J, Olofsson SO, Vikman K, and Edén S. Growth hormone regulation of serum lipoproteins in the rat: different growth hormone regulatory principles for apolipoprotein (apo) B and the sexually dimorphic apo E concentrations. Metabolism 11: 191-198, 1991.
33. Oscarsson J, Ottosson M, Vikman-Adolfsson K, Frick F, Enerbäck S, Lithell H, and Edén S. Growth hormone but not IGF-1 or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomized rats. J Endocrinol 160: 247-255, 1999.
34. Poggi C, Le Marchand-Brustel Y, Zapf J, Froesch ER, and Freychet P. Effects and binding of insulin-like growth factor 1 in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology 105: 723-730, 1979.
35. Quaife CJ, Mathews LS, Pinkert CA, Hammer R, Brinster RL, and Palmiter RD. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor 1 in transgenic mice. Endocrinology 124: 40-48, 1989.
36. Rennert NJ, Caprio S, and Sherwin RS. Insulin-like growth factor 1 inhibits glucose-stimulated insulin secretion but does not impair glucose metabolism in normal humans. J Clin Endocrinol Metab 76: 804-806, 1993.
37. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239: 375-380, 1964.
38. Schmitz F, Hartmann H, Stümpel F, and Creutzfeldt W. In vivo metabolic action of insulin like growth factor 1 in adult rats. Diabetologia 34: 144-149, 1991.
39. Schoenle E, Zapf J, Humbel R, and Froesch ER. Insulin-like growth factor 1 stimulates growth in hypophysectomized rats. Nature 296: 252-253, 1982.
40. Sjöberg A, Oscarsson J, Olofsson SO, and Edén S. Insulin-like growth factor and growth hormone have different effects on serum lipoproteins and secretion of lipoproteins from cultured rat hepatocytes. Endocrinology 135: 1415-1421, 1994.
41. Smith U, Sjöström L, and Björntorp P. Comparison of two methods of determining human adipose cell size. J Lipid Res 13: 822-824, 1972.
42. Tamura K, Kobayashi M, Ishii Y, Tamura T, Hashimoto K, Nakumara S, Niwa M, and Zapf J. Primary structure of rat insulin-like growth factor-1 and its biological activities. J Biol Chem 264: 5616-5621, 1989.
43. Thorngren KG and Hansson LI. Effect of thyroxine and growth hormone on longitudinal bone growth in the hypophysectomized rat. Acta Endocrinol 74: 24-40, 1973.
44. Tomas FM, Knowles SE, Owens PC, Chandler CS, Francis GL, and Ballard FJ. Insulin-like growth factor-1 and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects. Biochem J 291: 781-786, 1993.
45. Woodall SM, Breier BH, O'Sullivan U, and Gluckman PD. The effect of the frequency of subcutaneous insulin-like growth factor-1 administration on weight gain in growth hormone deficient mice. Horm Metab Res 23: 581-584, 1991.
46. Yang S, Björntorp P, Xinglu L, and Edén S. Growth hormone treatment of hypophysectomized rats increases catecholamine-induced lipolysis and the number of β-adrenergic receptors in adipocytes: no differences in the effects of growth hormone on different fat depots. Obes Res 4: 471-478, 1996.
47. Yu KT and Czech MP. The type 1 insulin-like growth factor receptor mediates the rapid effects of multiplication-stimulation activity on membrane transport systems in rat soleus muscle. J. Biol. Chem. 259: 3090-3095, 1984.
48. Zapf J, Schoenle E, Waldvogel M, Sand I, and Froesch ER. Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors. Eur. J. Biochem. 113: 605-609, 1981.